Skip to content

Evaluation of post-cesarean pain After Intraperitoneal Lidocaine Instillation versus intravenous lidocaine

Evaluation of post-cesarean pain After Intraperitoneal Lidocaine Instillation versus intravenous lidocaine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201506001145361
Enrollment
110
Registered
2015-05-16
Start date
2015-01-12
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery analgesia and prevention of pain Anaesthesia

Interventions

intraperitoneal instillation group

Sponsors

benha university hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1-Singleton pregnancy, 2-more than or equal completed 37 gestational weeks, 3-indicated to undergo elective cesarean delivery for various indications e.g., primigravida with breech presentation, macrosomia, intrauterine growth restriction and contracted pelvis, 4-willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1-extreme of age (below 18 ¿ above 40 year), 2-uncooperative patients, 3-previous abdominal scars, including previous cesarean or myomectomy, multiple gestation, 4-BMI >35 kg/m², chorioamnionitis, hypersensitivity or contraindications to lidocaine, 5-bronchial asthma, 6-bleeding diathesis, 7-pregnancy induced-hypertension, 8-liver or kidney diseases, 9-diabetes mellitus, 9-patients with psychological disturbance, 10-any form of chronic pain before or during pregnancy

Design outcomes

Primary

MeasureTime frame
pain score

Secondary

MeasureTime frame
analgesic requirements

Countries

Egypt

Contacts

Public ContactMohamed Abd Elhadi Mohamed Farag

assistant professor of obstetric and gynecology, faculty of medicine, benha university

Mohamed.farah01@fmed.bu.edu.eg0020 1227858660

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026